Cargando…
Ivermectin for Coronavirus Disease 2019: Yet to Be Well Evaluated Before Clinical Use
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8272976/ https://www.ncbi.nlm.nih.gov/pubmed/34362568 http://dx.doi.org/10.1016/j.clinthera.2021.07.007 |
| _version_ | 1783721291754242048 |
|---|---|
| author | Hagiya, Hideharu Otsuka, Fumio |
| author_facet | Hagiya, Hideharu Otsuka, Fumio |
| author_sort | Hagiya, Hideharu |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8272976 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-82729762021-07-20 Ivermectin for Coronavirus Disease 2019: Yet to Be Well Evaluated Before Clinical Use Hagiya, Hideharu Otsuka, Fumio Clin Ther Correspondence Elsevier Inc. 2021-09 2021-07-12 /pmc/articles/PMC8272976/ /pubmed/34362568 http://dx.doi.org/10.1016/j.clinthera.2021.07.007 Text en © 2021 Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Correspondence Hagiya, Hideharu Otsuka, Fumio Ivermectin for Coronavirus Disease 2019: Yet to Be Well Evaluated Before Clinical Use |
| title | Ivermectin for Coronavirus Disease 2019: Yet to Be Well Evaluated Before Clinical Use |
| title_full | Ivermectin for Coronavirus Disease 2019: Yet to Be Well Evaluated Before Clinical Use |
| title_fullStr | Ivermectin for Coronavirus Disease 2019: Yet to Be Well Evaluated Before Clinical Use |
| title_full_unstemmed | Ivermectin for Coronavirus Disease 2019: Yet to Be Well Evaluated Before Clinical Use |
| title_short | Ivermectin for Coronavirus Disease 2019: Yet to Be Well Evaluated Before Clinical Use |
| title_sort | ivermectin for coronavirus disease 2019: yet to be well evaluated before clinical use |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8272976/ https://www.ncbi.nlm.nih.gov/pubmed/34362568 http://dx.doi.org/10.1016/j.clinthera.2021.07.007 |
| work_keys_str_mv | AT hagiyahideharu ivermectinforcoronavirusdisease2019yettobewellevaluatedbeforeclinicaluse AT otsukafumio ivermectinforcoronavirusdisease2019yettobewellevaluatedbeforeclinicaluse |